Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent pharmacologic advances in antidepressant therapy

C D Kilts1

  • 1Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322.

The American Journal of Medicine
|December 19, 1994
PubMed
Summary

Newer antidepressants like SSRIs target serotonin (5-HT) for major depression treatment. Shared mechanisms among antidepressants suggest unified action, with neuroimaging aiding future drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Competing Motivations: Proactive Response Inhibition Toward Addiction-Related Stimuli in Quitting-Motivated Individuals.

Journal of gambling studies·2017
Same author

Neural activity during attentional conflict predicts reduction in tinnitus perception following rTMS.

Brain stimulation·2017
Same author

Changes in functional connectivity of the amygdala during cognitive reappraisal predict symptom reduction during trauma-focused cognitive-behavioral therapy among adolescent girls with post-traumatic stress disorder.

Psychological medicine·2016
Same author

Differential functional connectivity within an emotion regulation neural network among individuals resilient and susceptible to the depressogenic effects of early life stress.

Psychological medicine·2012
Same author

The simultaneous quantification of dopamine, norepinephrine and epinephrine in micropunched rat brain nuclei by on-line trace enrichment HPLC with electrochemical detection: Distribution of catecholamines in the limbic system.

Neurochemistry international·2010
Same author

Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).

Journal of psychiatric research·2008

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Major depression involves 5-hydroxytryptamine (serotonin) dysfunction.
  • Newer antidepressants exhibit distinct serotonergic properties compared to older ones.

Purpose of the Study:

  • To explore the role of serotonin in major depression pathophysiology and treatment.
  • To compare the mechanisms of action of different antidepressant classes.
  • To highlight the utility of neuroimaging in understanding antidepressant effects.

Main Methods:

  • Analysis of clinical differences between SSRIs and TCAs.
  • Examination of shared adaptive regulations in neurotransmission (noradrenergic, 5-HT, glutamate).
  • Review of in vivo neuroimaging techniques (PET, SPECT) in major depression.

Main Results:

  • SSRIs show greater potency and selectivity for 5-HT transporter inhibition than TCAs.
  • SSRIs have weaker interactions with non-serotonin receptors.
  • Common adaptive regulation suggests unifying antidepressant mechanisms.

Conclusions:

  • Serotonergic pathways are crucial in major depression.
  • Distinct and shared mechanisms exist across antidepressant classes.
  • Neuroimaging is vital for future antidepressant drug development and understanding treatment effects.

Related Experiment Videos